nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP3A4—bone cancer	0.861	1	CbGaD
Rotigotine—Haematocrit decreased—Methotrexate—bone cancer	0.00195	0.0209	CcSEcCtD
Rotigotine—Infection—Carboplatin—bone cancer	0.0016	0.0172	CcSEcCtD
Rotigotine—Dysaesthesia—Epirubicin—bone cancer	0.00157	0.0169	CcSEcCtD
Rotigotine—Dysaesthesia—Doxorubicin—bone cancer	0.00145	0.0156	CcSEcCtD
Rotigotine—Pain—Carboplatin—bone cancer	0.00138	0.0148	CcSEcCtD
Rotigotine—Hiccups—Cisplatin—bone cancer	0.00132	0.0142	CcSEcCtD
Rotigotine—Skin exfoliation—Cisplatin—bone cancer	0.00126	0.0136	CcSEcCtD
Rotigotine—Fluid retention—Cisplatin—bone cancer	0.00126	0.0135	CcSEcCtD
Rotigotine—Nasal congestion—Cisplatin—bone cancer	0.00105	0.0113	CcSEcCtD
Rotigotine—Irritability—Cisplatin—bone cancer	0.000917	0.00985	CcSEcCtD
Rotigotine—Orthostatic hypotension—Cisplatin—bone cancer	0.000878	0.00943	CcSEcCtD
Rotigotine—Breast disorder—Cisplatin—bone cancer	0.000868	0.00933	CcSEcCtD
Rotigotine—Nasopharyngitis—Cisplatin—bone cancer	0.000859	0.00923	CcSEcCtD
Rotigotine—Sweating increased—Cisplatin—bone cancer	0.000809	0.00869	CcSEcCtD
Rotigotine—Inflammation—Methotrexate—bone cancer	0.000749	0.00805	CcSEcCtD
Rotigotine—Dyskinesia—Epirubicin—bone cancer	0.000723	0.00777	CcSEcCtD
Rotigotine—Inflammation—Epirubicin—bone cancer	0.000701	0.00753	CcSEcCtD
Rotigotine—Skin exfoliation—Methotrexate—bone cancer	0.000694	0.00745	CcSEcCtD
Rotigotine—Musculoskeletal pain—Epirubicin—bone cancer	0.000688	0.00739	CcSEcCtD
Rotigotine—Hiccups—Epirubicin—bone cancer	0.00068	0.0073	CcSEcCtD
Rotigotine—Abnormal dreams—Epirubicin—bone cancer	0.000672	0.00722	CcSEcCtD
Rotigotine—Dyskinesia—Doxorubicin—bone cancer	0.000669	0.00719	CcSEcCtD
Rotigotine—Connective tissue disorder—Cisplatin—bone cancer	0.000653	0.00702	CcSEcCtD
Rotigotine—Skin exfoliation—Epirubicin—bone cancer	0.000649	0.00697	CcSEcCtD
Rotigotine—Inflammation—Doxorubicin—bone cancer	0.000649	0.00697	CcSEcCtD
Rotigotine—Fluid retention—Epirubicin—bone cancer	0.000645	0.00693	CcSEcCtD
Rotigotine—Visual impairment—Cisplatin—bone cancer	0.000641	0.00688	CcSEcCtD
Rotigotine—Musculoskeletal pain—Doxorubicin—bone cancer	0.000637	0.00684	CcSEcCtD
Rotigotine—Hiccups—Doxorubicin—bone cancer	0.000629	0.00676	CcSEcCtD
Rotigotine—Abnormal dreams—Doxorubicin—bone cancer	0.000622	0.00668	CcSEcCtD
Rotigotine—Tinnitus—Cisplatin—bone cancer	0.00062	0.00666	CcSEcCtD
Rotigotine—Skin exfoliation—Doxorubicin—bone cancer	0.000601	0.00645	CcSEcCtD
Rotigotine—Immune system disorder—Cisplatin—bone cancer	0.000601	0.00645	CcSEcCtD
Rotigotine—Mediastinal disorder—Cisplatin—bone cancer	0.000599	0.00644	CcSEcCtD
Rotigotine—Fluid retention—Doxorubicin—bone cancer	0.000597	0.00642	CcSEcCtD
Rotigotine—Abnormal vision—Epirubicin—bone cancer	0.000593	0.00637	CcSEcCtD
Rotigotine—Erythema—Cisplatin—bone cancer	0.000579	0.00622	CcSEcCtD
Rotigotine—Malnutrition—Cisplatin—bone cancer	0.000579	0.00622	CcSEcCtD
Rotigotine—Muscle spasms—Cisplatin—bone cancer	0.000556	0.00598	CcSEcCtD
Rotigotine—Eczema—Epirubicin—bone cancer	0.000549	0.0059	CcSEcCtD
Rotigotine—Abnormal vision—Doxorubicin—bone cancer	0.000549	0.00589	CcSEcCtD
Rotigotine—Tremor—Cisplatin—bone cancer	0.000542	0.00582	CcSEcCtD
Rotigotine—Lethargy—Methotrexate—bone cancer	0.000538	0.00578	CcSEcCtD
Rotigotine—Ill-defined disorder—Cisplatin—bone cancer	0.000537	0.00577	CcSEcCtD
Rotigotine—Hot flush—Epirubicin—bone cancer	0.000528	0.00567	CcSEcCtD
Rotigotine—Menopausal symptoms—Epirubicin—bone cancer	0.000523	0.00562	CcSEcCtD
Rotigotine—Malaise—Cisplatin—bone cancer	0.000522	0.00561	CcSEcCtD
Rotigotine—Eczema—Doxorubicin—bone cancer	0.000508	0.00546	CcSEcCtD
Rotigotine—Lethargy—Epirubicin—bone cancer	0.000504	0.00541	CcSEcCtD
Rotigotine—Irritability—Methotrexate—bone cancer	0.000503	0.00541	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000489	0.00526	CcSEcCtD
Rotigotine—Hot flush—Doxorubicin—bone cancer	0.000488	0.00524	CcSEcCtD
Rotigotine—Discomfort—Cisplatin—bone cancer	0.000487	0.00523	CcSEcCtD
Rotigotine—Menopausal symptoms—Doxorubicin—bone cancer	0.000484	0.0052	CcSEcCtD
Rotigotine—Breast disorder—Methotrexate—bone cancer	0.000477	0.00512	CcSEcCtD
Rotigotine—Infection—Cisplatin—bone cancer	0.000469	0.00504	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—bone cancer	0.000466	0.00501	CcSEcCtD
Rotigotine—Nervous system disorder—Cisplatin—bone cancer	0.000463	0.00498	CcSEcCtD
Rotigotine—Skin disorder—Cisplatin—bone cancer	0.000459	0.00493	CcSEcCtD
Rotigotine—Hyperhidrosis—Cisplatin—bone cancer	0.000457	0.00491	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—bone cancer	0.000451	0.00484	CcSEcCtD
Rotigotine—Anorexia—Cisplatin—bone cancer	0.00045	0.00484	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—bone cancer	0.000446	0.00479	CcSEcCtD
Rotigotine—Hypotension—Cisplatin—bone cancer	0.000441	0.00474	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—bone cancer	0.000441	0.00474	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00043	0.00462	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—bone cancer	0.000424	0.00456	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—bone cancer	0.000424	0.00455	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—bone cancer	0.00042	0.00451	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000417	0.00448	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—bone cancer	0.000413	0.00443	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—bone cancer	0.000411	0.00441	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—bone cancer	0.000408	0.00439	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000408	0.00438	CcSEcCtD
Rotigotine—Infestation—Methotrexate—bone cancer	0.000406	0.00437	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—bone cancer	0.000406	0.00437	CcSEcCtD
Rotigotine—Depression—Methotrexate—bone cancer	0.000405	0.00435	CcSEcCtD
Rotigotine—Pain—Cisplatin—bone cancer	0.000404	0.00434	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—bone cancer	0.000396	0.00426	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—bone cancer	0.000389	0.00418	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—bone cancer	0.000388	0.00417	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—bone cancer	0.000386	0.00415	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—bone cancer	0.00038	0.00409	CcSEcCtD
Rotigotine—Infestation—Epirubicin—bone cancer	0.00038	0.00409	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000367	0.00394	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—bone cancer	0.000359	0.00386	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—bone cancer	0.000357	0.00384	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—bone cancer	0.000357	0.00383	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—bone cancer	0.000352	0.00378	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—bone cancer	0.000352	0.00378	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—bone cancer	0.000352	0.00378	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—bone cancer	0.000348	0.00374	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—bone cancer	0.00034	0.00365	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—bone cancer	0.000339	0.00364	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—bone cancer	0.000336	0.00361	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—bone cancer	0.000336	0.0036	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—bone cancer	0.000331	0.00356	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—bone cancer	0.00033	0.00355	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—bone cancer	0.00033	0.00354	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—bone cancer	0.000329	0.00353	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—bone cancer	0.000329	0.00353	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—bone cancer	0.000323	0.00347	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—bone cancer	0.00032	0.00343	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—bone cancer	0.000318	0.00342	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—bone cancer	0.000318	0.00341	CcSEcCtD
Rotigotine—Erythema—Methotrexate—bone cancer	0.000318	0.00341	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—bone cancer	0.000311	0.00334	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—bone cancer	0.00031	0.00333	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—bone cancer	0.00031	0.00333	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—bone cancer	0.000308	0.00331	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—bone cancer	0.000308	0.00331	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—bone cancer	0.000304	0.00327	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—bone cancer	0.0003	0.00323	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—bone cancer	0.000299	0.00321	CcSEcCtD
Rotigotine—Rash—Cisplatin—bone cancer	0.000298	0.0032	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—bone cancer	0.000298	0.0032	CcSEcCtD
Rotigotine—Erythema—Epirubicin—bone cancer	0.000297	0.00319	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—bone cancer	0.000297	0.00319	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—bone cancer	0.000295	0.00317	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—bone cancer	0.000295	0.00316	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—bone cancer	0.000287	0.00308	CcSEcCtD
Rotigotine—Malaise—Methotrexate—bone cancer	0.000286	0.00308	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—bone cancer	0.000286	0.00307	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—bone cancer	0.000285	0.00307	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—bone cancer	0.000285	0.00307	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—bone cancer	0.000285	0.00306	CcSEcCtD
Rotigotine—Nausea—Cisplatin—bone cancer	0.000281	0.00301	CcSEcCtD
Rotigotine—Cough—Methotrexate—bone cancer	0.000277	0.00298	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—bone cancer	0.000277	0.00297	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—bone cancer	0.000276	0.00296	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—bone cancer	0.000275	0.00295	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—bone cancer	0.000275	0.00295	CcSEcCtD
Rotigotine—Agitation—Epirubicin—bone cancer	0.000273	0.00293	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—bone cancer	0.00027	0.0029	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000269	0.00288	CcSEcCtD
Rotigotine—Malaise—Epirubicin—bone cancer	0.000268	0.00288	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—bone cancer	0.000267	0.00287	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—bone cancer	0.000267	0.00287	CcSEcCtD
Rotigotine—Syncope—Epirubicin—bone cancer	0.000267	0.00286	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—bone cancer	0.000264	0.00284	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—bone cancer	0.000261	0.00281	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—bone cancer	0.000261	0.00281	CcSEcCtD
Rotigotine—Cough—Epirubicin—bone cancer	0.000259	0.00279	CcSEcCtD
Rotigotine—Infection—Methotrexate—bone cancer	0.000258	0.00277	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—bone cancer	0.000257	0.00276	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—bone cancer	0.000255	0.00274	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—bone cancer	0.000254	0.00273	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—bone cancer	0.000253	0.00272	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—bone cancer	0.000253	0.00271	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—bone cancer	0.000252	0.0027	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000251	0.0027	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—bone cancer	0.000251	0.00269	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—bone cancer	0.00025	0.00269	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—bone cancer	0.000248	0.00266	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—bone cancer	0.000247	0.00266	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—bone cancer	0.000247	0.00265	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—bone cancer	0.000247	0.00265	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—bone cancer	0.000247	0.00265	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—bone cancer	0.000245	0.00263	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—bone cancer	0.000242	0.0026	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—bone cancer	0.000242	0.0026	CcSEcCtD
Rotigotine—Infection—Epirubicin—bone cancer	0.000241	0.00259	CcSEcCtD
Rotigotine—Cough—Doxorubicin—bone cancer	0.00024	0.00258	CcSEcCtD
Rotigotine—Shock—Epirubicin—bone cancer	0.000239	0.00256	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—bone cancer	0.000238	0.00256	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—bone cancer	0.000237	0.00255	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000236	0.00254	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—bone cancer	0.000236	0.00253	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—bone cancer	0.000235	0.00252	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—bone cancer	0.000234	0.00252	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—bone cancer	0.000234	0.00251	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—bone cancer	0.000233	0.0025	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000233	0.0025	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—bone cancer	0.000231	0.00248	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—bone cancer	0.000231	0.00248	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—bone cancer	0.00023	0.00248	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—bone cancer	0.000229	0.00246	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—bone cancer	0.000228	0.00245	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—bone cancer	0.000227	0.00243	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—bone cancer	0.000226	0.00243	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—bone cancer	0.000225	0.00242	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000224	0.0024	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—bone cancer	0.000223	0.0024	CcSEcCtD
Rotigotine—Infection—Doxorubicin—bone cancer	0.000223	0.0024	CcSEcCtD
Rotigotine—Pain—Methotrexate—bone cancer	0.000222	0.00238	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000221	0.00237	CcSEcCtD
Rotigotine—Shock—Doxorubicin—bone cancer	0.000221	0.00237	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—bone cancer	0.00022	0.00236	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—bone cancer	0.000219	0.00236	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—bone cancer	0.000218	0.00234	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—bone cancer	0.000218	0.00234	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—bone cancer	0.000217	0.00233	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—bone cancer	0.000216	0.00232	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—bone cancer	0.000214	0.0023	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.00229	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—bone cancer	0.000214	0.00229	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—bone cancer	0.000211	0.00227	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—bone cancer	0.00021	0.00225	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000209	0.00225	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—bone cancer	0.000209	0.00225	CcSEcCtD
Rotigotine—Pain—Epirubicin—bone cancer	0.000207	0.00223	CcSEcCtD
Rotigotine—Constipation—Epirubicin—bone cancer	0.000207	0.00223	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—bone cancer	0.000206	0.00221	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000204	0.0022	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—bone cancer	0.000203	0.00218	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.00216	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.00215	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—bone cancer	0.0002	0.00214	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—bone cancer	0.000198	0.00212	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—bone cancer	0.000195	0.0021	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000194	0.00208	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—bone cancer	0.000194	0.00208	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—bone cancer	0.000193	0.00207	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—bone cancer	0.000192	0.00206	CcSEcCtD
Rotigotine—Pain—Doxorubicin—bone cancer	0.000192	0.00206	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—bone cancer	0.000191	0.00205	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—bone cancer	0.000186	0.002	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.00199	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—bone cancer	0.000183	0.00197	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—bone cancer	0.000179	0.00192	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—bone cancer	0.000178	0.00192	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—bone cancer	0.000177	0.00191	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—bone cancer	0.000174	0.00187	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—bone cancer	0.000172	0.00184	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—bone cancer	0.000171	0.00184	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00178	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—bone cancer	0.000165	0.00178	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—bone cancer	0.000165	0.00177	CcSEcCtD
Rotigotine—Rash—Methotrexate—bone cancer	0.000163	0.00176	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—bone cancer	0.000163	0.00175	CcSEcCtD
Rotigotine—Headache—Methotrexate—bone cancer	0.000162	0.00174	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—bone cancer	0.000161	0.00173	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—bone cancer	0.00016	0.00172	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—bone cancer	0.000159	0.00171	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—bone cancer	0.000154	0.00166	CcSEcCtD
Rotigotine—Nausea—Methotrexate—bone cancer	0.000154	0.00165	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.00165	CcSEcCtD
Rotigotine—Rash—Epirubicin—bone cancer	0.000153	0.00164	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—bone cancer	0.000153	0.00164	CcSEcCtD
Rotigotine—Headache—Epirubicin—bone cancer	0.000152	0.00163	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—bone cancer	0.000148	0.00159	CcSEcCtD
Rotigotine—Nausea—Epirubicin—bone cancer	0.000144	0.00155	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—bone cancer	0.000143	0.00153	CcSEcCtD
Rotigotine—Rash—Doxorubicin—bone cancer	0.000142	0.00152	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—bone cancer	0.000141	0.00152	CcSEcCtD
Rotigotine—Headache—Doxorubicin—bone cancer	0.000141	0.00151	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—bone cancer	0.000133	0.00143	CcSEcCtD
Rotigotine—DRD1—Circadian rythm related genes—CDK4—bone cancer	0.000113	0.00245	CbGpPWpGaD
Rotigotine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000112	0.00244	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—CDK4—bone cancer	0.000111	0.00242	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—RGS1—bone cancer	0.000109	0.00238	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—GRM4—bone cancer	0.000109	0.00238	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—GRM4—bone cancer	0.000108	0.00236	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—RGS1—bone cancer	0.000108	0.00236	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—GRM4—bone cancer	0.000107	0.00233	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—RGS1—bone cancer	0.000107	0.00233	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—GRM1—bone cancer	0.000104	0.00227	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—SMO—bone cancer	0.000104	0.00227	CbGpPWpGaD
Rotigotine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000101	0.00221	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—SMO—bone cancer	0.000101	0.00219	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—RGS1—bone cancer	9.84e-05	0.00214	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—GRM4—bone cancer	9.84e-05	0.00214	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	9.77e-05	0.00213	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—RGS1—bone cancer	9.71e-05	0.00211	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—GRM4—bone cancer	9.71e-05	0.00211	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—GRM4—bone cancer	9.65e-05	0.0021	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—RGS1—bone cancer	9.65e-05	0.0021	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—GRM1—bone cancer	9.48e-05	0.00206	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—GRM1—bone cancer	9.39e-05	0.00204	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—SPARC—bone cancer	9.33e-05	0.00203	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—RGS1—bone cancer	9.32e-05	0.00203	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—GRM4—bone cancer	9.32e-05	0.00203	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—GRM1—bone cancer	9.27e-05	0.00202	CbGpPWpGaD
Rotigotine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.14e-05	0.00199	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—GNA11—bone cancer	9.11e-05	0.00198	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.07e-05	0.00197	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—SMO—bone cancer	9.05e-05	0.00197	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	8.94e-05	0.00195	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—SMO—bone cancer	8.84e-05	0.00192	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	8.81e-05	0.00192	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—RGS1—bone cancer	8.76e-05	0.00191	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—GRM4—bone cancer	8.76e-05	0.00191	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—GRM4—bone cancer	8.75e-05	0.0019	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—RGS1—bone cancer	8.75e-05	0.0019	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—GNA11—bone cancer	8.53e-05	0.00186	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—GRM1—bone cancer	8.53e-05	0.00186	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—CDK4—bone cancer	8.51e-05	0.00185	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—RGS1—bone cancer	8.46e-05	0.00184	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—GRM4—bone cancer	8.46e-05	0.00184	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—GRM1—bone cancer	8.42e-05	0.00183	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—GRM1—bone cancer	8.37e-05	0.00182	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—GNA11—bone cancer	8.27e-05	0.0018	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—IL3—bone cancer	8.26e-05	0.0018	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—GRM4—bone cancer	8.18e-05	0.00178	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—RGS1—bone cancer	8.18e-05	0.00178	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—GRM1—bone cancer	8.08e-05	0.00176	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—JUN—bone cancer	8.07e-05	0.00175	CbGpPWpGaD
Rotigotine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.83e-05	0.0017	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.75e-05	0.00169	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—IL3—bone cancer	7.73e-05	0.00168	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	7.68e-05	0.00167	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.65e-05	0.00166	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	7.65e-05	0.00166	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—GRM1—bone cancer	7.6e-05	0.00165	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—GRM1—bone cancer	7.58e-05	0.00165	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.58e-05	0.00165	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL3—bone cancer	7.5e-05	0.00163	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—RGS1—bone cancer	7.43e-05	0.00162	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—GRM4—bone cancer	7.43e-05	0.00162	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—GRM1—bone cancer	7.34e-05	0.0016	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—JUN—bone cancer	7.26e-05	0.00158	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—JUN—bone cancer	7.16e-05	0.00156	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—GRM1—bone cancer	7.09e-05	0.00154	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	6.93e-05	0.00151	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	6.93e-05	0.00151	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—GNA11—bone cancer	6.72e-05	0.00146	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—SMO—bone cancer	6.68e-05	0.00145	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.57e-05	0.00143	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.48e-05	0.00141	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—GRM4—bone cancer	6.46e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—RGS1—bone cancer	6.46e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—GRM1—bone cancer	6.44e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—GNA11—bone cancer	6.11e-05	0.00133	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—IL3—bone cancer	6.1e-05	0.00133	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—GNA11—bone cancer	6.05e-05	0.00132	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—SMO—bone cancer	6.01e-05	0.00131	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—GNA11—bone cancer	5.97e-05	0.0013	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—SMO—bone cancer	5.93e-05	0.00129	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—GRM4—bone cancer	5.81e-05	0.00126	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RGS1—bone cancer	5.81e-05	0.00126	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—GRM4—bone cancer	5.73e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RGS1—bone cancer	5.73e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—GRM1—bone cancer	5.6e-05	0.00122	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL3—bone cancer	5.54e-05	0.0012	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—GNA11—bone cancer	5.5e-05	0.0012	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—IL3—bone cancer	5.49e-05	0.00119	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—JUN—bone cancer	5.48e-05	0.00119	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NDUFA12—bone cancer	5.43e-05	0.00118	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—GNA11—bone cancer	5.42e-05	0.00118	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—IL3—bone cancer	5.41e-05	0.00118	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—GNA11—bone cancer	5.39e-05	0.00117	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—SMO—bone cancer	5.35e-05	0.00116	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SMO—bone cancer	5.34e-05	0.00116	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—bone cancer	5.32e-05	0.00116	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—GNA11—bone cancer	5.21e-05	0.00113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GRM4—bone cancer	5.18e-05	0.00113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RGS1—bone cancer	5.18e-05	0.00113	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—SMO—bone cancer	5.17e-05	0.00112	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—PLAU—bone cancer	5.07e-05	0.0011	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.07e-05	0.0011	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—GRM1—bone cancer	5.04e-05	0.0011	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5e-05	0.00109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RGS1—bone cancer	5e-05	0.00109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GRM4—bone cancer	5e-05	0.00109	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL3—bone cancer	4.98e-05	0.00108	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—GRM1—bone cancer	4.97e-05	0.00108	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL3—bone cancer	4.92e-05	0.00107	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—GNA11—bone cancer	4.9e-05	0.00107	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—IL3—bone cancer	4.89e-05	0.00106	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—GNA11—bone cancer	4.89e-05	0.00106	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—bone cancer	4.79e-05	0.00104	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—bone cancer	4.73e-05	0.00103	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—GNA11—bone cancer	4.73e-05	0.00103	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—IL3—bone cancer	4.72e-05	0.00103	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NDUFA12—bone cancer	4.6e-05	0.001	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—GNA11—bone cancer	4.57e-05	0.000994	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ATF1—bone cancer	4.54e-05	0.000988	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—SMO—bone cancer	4.54e-05	0.000987	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NT5C3A—bone cancer	4.5e-05	0.00098	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GRM1—bone cancer	4.49e-05	0.000977	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL3—bone cancer	4.44e-05	0.000966	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL3—bone cancer	4.43e-05	0.000964	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RGS1—bone cancer	4.39e-05	0.000955	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GRM4—bone cancer	4.39e-05	0.000955	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GRM1—bone cancer	4.33e-05	0.000943	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL3—bone cancer	4.29e-05	0.000932	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—GNA11—bone cancer	4.15e-05	0.000903	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—IL3—bone cancer	4.14e-05	0.000901	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SMO—bone cancer	3.94e-05	0.000858	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NT5C3A—bone cancer	3.81e-05	0.00083	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GRM1—bone cancer	3.8e-05	0.000828	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFBR2—bone cancer	3.79e-05	0.000824	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL3—bone cancer	3.76e-05	0.000819	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—bone cancer	3.62e-05	0.000787	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—GNA11—bone cancer	3.61e-05	0.000785	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IGF1R—bone cancer	3.57e-05	0.000776	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.55e-05	0.000773	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SMO—bone cancer	3.55e-05	0.000772	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SMO—bone cancer	3.5e-05	0.000762	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ATF1—bone cancer	3.35e-05	0.000729	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL3—bone cancer	3.27e-05	0.000711	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—GNA11—bone cancer	3.25e-05	0.000706	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—GNA11—bone cancer	3.2e-05	0.000697	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SMO—bone cancer	3.16e-05	0.000688	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SMO—bone cancer	3.05e-05	0.000664	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ATF1—bone cancer	3.02e-05	0.000657	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ATF1—bone cancer	2.98e-05	0.000648	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.94e-05	0.00064	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL3—bone cancer	2.94e-05	0.00064	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL3—bone cancer	2.9e-05	0.000632	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GNA11—bone cancer	2.89e-05	0.000629	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFBR2—bone cancer	2.8e-05	0.000608	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GNA11—bone cancer	2.79e-05	0.000607	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ATF1—bone cancer	2.69e-05	0.000585	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SMO—bone cancer	2.68e-05	0.000583	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IGF1R—bone cancer	2.63e-05	0.000572	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL3—bone cancer	2.62e-05	0.00057	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ATF1—bone cancer	2.6e-05	0.000565	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KIT—bone cancer	2.59e-05	0.000563	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL3—bone cancer	2.53e-05	0.000551	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.52e-05	0.000548	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.00054	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GNA11—bone cancer	2.45e-05	0.000533	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—BRAF—bone cancer	2.43e-05	0.000529	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IGF1R—bone cancer	2.37e-05	0.000515	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—EGFR—bone cancer	2.36e-05	0.000512	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IGF1R—bone cancer	2.34e-05	0.000508	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ATF1—bone cancer	2.28e-05	0.000496	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.24e-05	0.000488	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL3—bone cancer	2.22e-05	0.000484	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.17e-05	0.000471	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.11e-05	0.000459	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—bone cancer	2.04e-05	0.000444	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.04e-05	0.000443	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MDM2—bone cancer	2.04e-05	0.000443	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ENO2—bone cancer	1.97e-05	0.000429	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KIT—bone cancer	1.91e-05	0.000415	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.9e-05	0.000414	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—DHFR—bone cancer	1.83e-05	0.000398	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—BRAF—bone cancer	1.79e-05	0.00039	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.79e-05	0.000389	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—JUN—bone cancer	1.77e-05	0.000385	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—bone cancer	1.74e-05	0.000378	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—bone cancer	1.72e-05	0.000375	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000374	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GNA11—bone cancer	1.71e-05	0.000372	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KIT—bone cancer	1.7e-05	0.000369	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ENO2—bone cancer	1.67e-05	0.000364	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—BRAF—bone cancer	1.61e-05	0.000351	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—BRAF—bone cancer	1.59e-05	0.000347	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000341	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.55e-05	0.000337	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—DHFR—bone cancer	1.55e-05	0.000337	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—bone cancer	1.54e-05	0.000336	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KIT—bone cancer	1.53e-05	0.000333	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MDM2—bone cancer	1.5e-05	0.000327	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KIT—bone cancer	1.48e-05	0.000321	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GNA11—bone cancer	1.45e-05	0.000315	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.44e-05	0.000313	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.39e-05	0.000303	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—bone cancer	1.39e-05	0.000303	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.39e-05	0.000302	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MDM2—bone cancer	1.35e-05	0.000294	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.35e-05	0.000293	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.00029	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTP1—bone cancer	1.33e-05	0.000288	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.31e-05	0.000286	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.31e-05	0.000284	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—JUN—bone cancer	1.31e-05	0.000284	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KIT—bone cancer	1.3e-05	0.000282	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO2—bone cancer	1.29e-05	0.000281	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—bone cancer	1.27e-05	0.000277	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—bone cancer	1.22e-05	0.000265	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.21e-05	0.000262	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—DHFR—bone cancer	1.2e-05	0.00026	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.18e-05	0.000257	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—bone cancer	1.18e-05	0.000256	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—bone cancer	1.17e-05	0.000254	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.16e-05	0.000253	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—bone cancer	1.16e-05	0.000252	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—bone cancer	1.14e-05	0.000249	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—bone cancer	1.13e-05	0.000246	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—bone cancer	1.12e-05	0.000244	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNA11—bone cancer	1.12e-05	0.000243	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.05e-05	0.000228	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—bone cancer	1.03e-05	0.000223	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—bone cancer	1.02e-05	0.000222	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.02e-05	0.000222	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—bone cancer	1.01e-05	0.00022	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—bone cancer	9.84e-06	0.000214	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—bone cancer	9.25e-06	0.000201	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—bone cancer	9.12e-06	0.000198	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—bone cancer	8.88e-06	0.000193	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—bone cancer	8.67e-06	0.000189	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—bone cancer	8.64e-06	0.000188	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—bone cancer	8.62e-06	0.000188	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—bone cancer	8.24e-06	0.000179	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—bone cancer	7.95e-06	0.000173	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—bone cancer	7.76e-06	0.000169	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—bone cancer	7.66e-06	0.000167	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—bone cancer	6.98e-06	0.000152	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—bone cancer	6.92e-06	0.00015	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—bone cancer	6.87e-06	0.000149	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—bone cancer	6.68e-06	0.000145	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—bone cancer	5.86e-06	0.000128	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—bone cancer	5.82e-06	0.000127	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—bone cancer	4.49e-06	9.77e-05	CbGpPWpGaD
